[Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials]. 2007

Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

OBJECTIVE To compare different expression profiles of all known chemokine receptors in human hepatocellular carcinoma (HCC) cell lines with different metastasis potentials. METHODS Eighteen pairs of chemokine receptor primers were designed using Premier software. Expression profiles of the 18 chemokine receptors on four HCC cell lines of lower to higher potentials of metastasis (SMMC-7721, MHCC97-L, MHCC97-H and HCCLM6) were analyzed by RT-PCR. Expression of CXCR4 was detected by RT-PCR. RESULTS Expression profiles of chemokine receptors on four HCC cell lines with different metastatic potentials had significant differences (P < 0.01), in which CCR10, CXCR4 and CXCR6 expressions decreased gradually as the metastatic potential of the cell lines increased. The expressions of CCR3, CCR4, CCR10, CCR12 and XCR1 on HCCLM6 were significantly reduced compared with SMMC-7721 (P < 0.01), whereas the expressions of CXCR1 (P = 0.006) and CXCR5 (P = 0.003) exceeded that of SMMC-7721. Except for CXCR2, CXCR6 and XCR1, most of chemokine receptors on MHCC97-H were expressed differently compared with MHCC97-L (P < 0.05), in which expressions of CCR1 (P = 0.002), CCR2 (P = 0.004) and CCR5 (P = 0.046) exceeded MHCC97-L. CXCR4 was detected only on the positive controls and SMMC-7721 when the template of total RNA was reduced one-half in RT-PCR. CONCLUSIONS Chemokine receptors are expressed very differently at mRNA level on HCC cell lines with different metastatic potentials. The different profiles of chemokine receptors in tumor microenvironment and the function of CXCR4 in HCC should be further studied. Our findings have important implications in understanding the relationship between chemokine receptors and the metastatic potential of HCC.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D019707 Receptors, Chemokine Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif. Chemokine Receptor,Chemokine Receptors,Receptor, Chemokine

Related Publications

Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
January 2006, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
November 2008, Journal of cancer research and clinical oncology,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
September 2007, Cancer investigation,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
June 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
December 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
July 2018, Oncology letters,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
October 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
January 2011, Molecular medicine reports,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
May 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Tong-chun Xue, and Rong-xin Chen, and Sheng-long Ye, and Ru-xia Sun, and Jie Chen, and Zhao-you Tang
November 2009, Cytotechnology,
Copied contents to your clipboard!